Cigna vs Costco Stock: Which Is Best?
Cigna and Costco don’t usually go hand in hand but…
Sell
45
NUTX Quote, Financials, Valuation and Earnings
Last price:
$38.25
Seasonality move
:
50.58%
Day range:
$32.80 - $37.86
52-week range:
$4.16 - $41.44
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.48x
P/B ratio:
3.41x
Volume:
27.5K
Avg. volume:
34.3K
1-year change:
29.44%
Market cap:
$205.8M
Revenue:
$247.6M
EPS (TTM):
-$10.79
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Nutex Health has 46.15% upside to fair value with a price target of -- per share.
NUTX vs. S&P 500
-
Over the past 5 trading days, Nutex Health has overperformed the S&P 500 by 17.25% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Nutex Health does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Nutex Health has grown year-over-year revenues for 6 quarters straight. In the most recent quarter Nutex Health reported revenues of $78.8M.
Earnings Growth
-
Nutex Health has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Nutex Health reported earnings per share of -$1.72.
Enterprise value:
219M
EV / Invested capital:
--
Price / LTM sales:
0.48x
EV / EBIT:
--
EV / Revenue:
0.75x
PEG ratio (5yr expected):
--
EV / Free cash flow:
10.82x
Price / Operating cash flow:
6.93x
Enterprise value / EBITDA:
27.54x
Gross Profit (TTM):
$67.8M
Return On Assets:
-9.6%
Net Income Margin (TTM):
-14.09%
Return On Equity:
-48.3%
Return On Invested Capital:
-32.79%
Operating Margin:
12.8%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $229M | $231.7M | $292M | $62.7M | $78.8M | |
| Gross Profit | $38.2M | $18.2M | $67.8M | $7.1M | $21.9M | |
| Operating Income | $20.3M | -$11.4M | $27.6M | -$777.8K | $10.1M | |
| EBITDA | -$374.2M | $4.5M | $8M | $4M | $7.8M | |
| Diluted EPS | -$89.25 | -$23.04 | -$10.79 | -$1.25 | -$1.72 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $180.3M | $107.5M | $89.9M | $119.8M | |
| Total Assets | -- | $372.1M | $434.5M | $479.6M | $438.5M | |
| Current Liabilities | -- | $40.7M | $43.8M | $67.3M | $67.6M | |
| Total Liabilities | -- | $159M | $302M | $374.7M | $358.7M | |
| Total Equity | -- | $213.1M | $132.5M | $104.9M | $79.8M | |
| Total Debt | -- | $91.6M | $31.3M | $42.3M | $40.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $92.5M | $7.5M | $21.3M | $2M | $6.8M | |
| Cash From Investing | -$24M | -$4.2M | -$1.4M | -$3.6M | -$267.2K | |
| Cash From Financing | -$66.2M | -$13.1M | $162.8K | -$4.3M | -$421K | |
| Free Cash Flow | $58.3M | $5.1M | $20.2M | -$907.2K | $6.2M | |
NUTX
Sector
Market Cap
$205.8M
$45.4M
Price % of 52-Week High
91.36%
46.67%
Dividend Yield
0%
0%
Shareholder Yield
--
-0.74%
1-Year Price Total Return
29.44%
-33.9%
Beta (5-Year)
0.178
0.747
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
-11.03%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$32.97
200-day SMA
Buy
Level
$17.59
Bollinger Bands (100)
Buy
Level
21.37 - 33.35
Chaikin Money Flow
Sell
Level
-103.2M
20-day SMA
Buy
Level
$32.22
Relative Strength Index (RSI14)
Buy
Level
63.65
ADX Line
Buy
Level
15.66
Williams %R
Sell
Level
0
50-day SMA
Buy
Level
$32.65
MACD (12, 26)
Buy
Level
0.37
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Neutral
Level
234.2M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.7558)
Sell
CA Score
(Annual)
Level (-2.006)
Buy
Beneish M-Score
(Annual)
Level (-3.365)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (7.548)
Buy
Piotroski F Score
(Annual)
Level (7)
Sell
Quality Ratio Score
Level (3)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Nutex Health Inc is healthcare services and operations company with 20 hospital facilities in eight states (hospital division), and a primary care-centric, risk-bearing population health management division. The hospital division implements and operates healthcare models, including micro-hospitals, specialty hospitals and hospital outpatient departments (HOPDs). The population health management division owns and operates provider networks such as independent physician associations (IPAs) and offers a cloud-based proprietary technology platform to IPAs that aggregates clinical and claims data across multiple settings, information systems and sources to create a holistic view of patients and providers.
Stock Forecast FAQ
In the current month, NUTX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The NUTX average analyst price target in the past 3 months is --.
-
Where Will Nutex Health Stock Be In 1 Year?
According to analysts, the consensus estimate is that Nutex Health share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Nutex Health?
Analysts are divided on their view about Nutex Health share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Nutex Health is a Sell and believe this share price will drop from its current level to --.
-
What Is Nutex Health's Price Target?
The price target for Nutex Health over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is NUTX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Nutex Health is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of NUTX?
You can purchase shares of Nutex Health via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Nutex Health shares.
-
What Is The Nutex Health Share Price Today?
Nutex Health was last trading at $38.25 per share. This represents the most recent stock quote for Nutex Health. Yesterday, Nutex Health closed at $37.86 per share.
-
How To Buy Nutex Health Stock Online?
In order to purchase Nutex Health stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will T-Mobile Stock Recover?
Last year was a stellar year for telecom giant T-Mobile…
Why Is Stanley Druckenmiller Buying Citigroup?
As recently as 2020, few analysts could have predicted that…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Sell
47
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 112x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
40
NUKK alert for Jan 17
Nukkleus [NUKK] is up 55.67% over the past day.
Buy
71
SYM alert for Jan 17
Symbotic [SYM] is down 4.46% over the past day.
Sell
45
NUTX alert for Jan 17
Nutex Health [NUTX] is up 5.1% over the past day.
